Sales and Marketing

Showing 15 posts of 11524 posts found.

Bayer raises bid yet again to finalise Monsanto deal

September 14, 2016 Manufacturing and Production, Research and Development, Sales and Marketing

Bayer has taken yet another step in its dedicated efforts to acquire Monsanto as it raises its offer to $129 …
rick_farris

ClinTec appoints Rick Farris as executive vice president of North American Operations

September 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ClinTec, appointment

Clinical research organisation ClinTec has announced the expansion of its US management team with the selection of Rick Farris as …
gsk_hq_close

GSK and J&J file rheumatoid arthritis treatment sirukumab in EU

September 13, 2016 Manufacturing and Production, Sales and Marketing GSK, GlaxoSmithKline, Johnson & Johnson, rheumatoid arthritis, sarilumab, sirukumab

GlaxoSmithKline and partner Johnson & Johnson’s Janssen Biologics unit have filed for approval of rheumatoid arthritis (RA) treatment sirukumab in …
shutterstock_273326141

Horizon buys out Raptor for $800 million

September 13, 2016 Manufacturing and Production, Sales and Marketing Horizon Pharma, Raptor Pharmaceutical, acquisition

Irish biopharmaceutical firm Horizon Pharma has finalised an $800 million deal to buy Raptor Pharmaceutical Corp in a bid to …

New Sanofi/Alphabet partnership names CEO

September 12, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alphabet, Sanofi, Verily, appointment, google

As part of the news that French drugmaker Sanofi and Google parent Alphabet’s life sciences firm Verily are to join …
als_ely_facility

ALS Pharma quadruples Cambridgeshire testing facility in £2m expansion

September 12, 2016 Manufacturing and Production, Research and Development, Sales and Marketing ALS Pharmaceutical, Microbiology, expansion

UK microbiology and chemical analysis company ALS Pharmaceutical has quadrupled the size of its facility in Ely, Cambridgeshire as part …

Bayer ponders $1.1 billion portfolio sale to fund Monsanto acquisition

September 12, 2016 Business Services, Manufacturing and Production, Sales and Marketing Bayer, acquisition, monsanto

In the latest development in the Bayer-Monsanto saga, the German drugmaker has enlisted the aid of global financial services firm …

GSK sells anaesthetic portfolio to Aspen for up to $372 million

September 12, 2016 Sales and Marketing

GlaxoSmithKline is to sell its portfolio of anaesthetic drugs to South African firm Aspen Pharmacare in a deal worth up …
ianreadweb

Clinton plan “negative for innovation”, says Pfizer CEO

September 12, 2016 Sales and Marketing Hilary Clinton

Democrat presidential candidate Hilary Clinton’s plan to tackle “unjustified price hikes” outlined last week is “very negative for innovation”, according …
google

Sanofi and Google forge $500 million diabetes partnership

September 12, 2016 Research and Development, Sales and Marketing Alphabet, Sanofi, Verily, diabetes, google

Sanofi is set to join forces with Alphabet’s life sciences firm Verily in a $500 million partnership to develop diabetes …
afd-69766

Gilead appoints former Roche executive

September 9, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, Roche, appointment

Gilead Sciences has hired Rogers Luo as vice president and general manager of commercial operations in China. Luo formerly served …

Pfizer launches legal action to block Xeljanz copies in India

September 9, 2016 Medical Communications, Sales and Marketing Pfizer, Sun Pharma, Xeljanz, Zydus Cadila, rheumatoid arthritis

Pfizer has pre-emptively sued a number of India-based drug companies including Sun Pharma and Zydus Cadila to block any attempts …
fda2outsideweb

FDA approves Dechra’s generic antibiotic

September 9, 2016 Medical Communications, Sales and Marketing Dechra, Putney, antiobiotic, generic

Dechra has announced that the US Food and Drug Administration (FDA) has approved its generic antibiotic. The product will be …
celgene_1_02

Celgene and Agios to file FDA application for “first-in-class” cancer drug

September 8, 2016 Research and Development, Sales and Marketing Celgene, FDA, NDA, acute myeloid leukaemia, agios

According to an SEC 8-K filing by Agios, the company and its partner Celgene intend to file a new drug …
The Gateway to Local Adoption Series

Latest content